Associated with metabolic syndromes, NAFLD is increasingly being recognized as a major cause of liver disease
The last involves oxygen reduction and is a process that can act to balance chloroplast ATP:NADPH ratios or function as an alternative sink for electrons but which also generates ROS as intermediates (Allen and Hall 1974
43 Indeed, this may explain the potent metabolic effects of tirzepatide when pitted against a GLP-1 agonist alone
In addition, Knapen (221) also found that the use of incretin drugs could increase the risk of pancreatic cancer by 1.7 times
This is especially important because a lot of people carrying extra weight also have excess fat built up in and around the liver (sometimes called fatty liver), which can cause its own health problems
"l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor- levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial." National Library of Medicine
